Zeyuan Lu

1.0k total citations
29 papers, 715 citations indexed

About

Zeyuan Lu is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Zeyuan Lu has authored 29 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Zeyuan Lu's work include Acute Kidney Injury Research (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Pancreatic function and diabetes (6 papers). Zeyuan Lu is often cited by papers focused on Acute Kidney Injury Research (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Pancreatic function and diabetes (6 papers). Zeyuan Lu collaborates with scholars based in China, United States and Australia. Zeyuan Lu's co-authors include Feng Wang, Fangfei Zhang, Mingyu Liang, Niansong Wang, Guangyuan Zhang, Jianyong Yin, Na Liu, Rui Wu, Feng Wang and Yiwei Kong and has published in prestigious journals such as Scientific Reports, Kidney International and Life Sciences.

In The Last Decade

Zeyuan Lu

29 papers receiving 704 citations

Peers

Zeyuan Lu
Hequn Zou China
Katherine Fredrich United States
Tomokazu Okado Japan
Ryohei Kaseda Japan
Stephen Zewinger Germany
Kerstin Ebefors Sweden
Jung Sik Park South Korea
Pierre Galichon France
E.S.G. Stroes Netherlands
Hequn Zou China
Zeyuan Lu
Citations per year, relative to Zeyuan Lu Zeyuan Lu (= 1×) peers Hequn Zou

Countries citing papers authored by Zeyuan Lu

Since Specialization
Citations

This map shows the geographic impact of Zeyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyuan Lu more than expected).

Fields of papers citing papers by Zeyuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyuan Lu. The network helps show where Zeyuan Lu may publish in the future.

Co-authorship network of co-authors of Zeyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyuan Lu. A scholar is included among the top collaborators of Zeyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyuan Lu. Zeyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Juan, Ling Wang, Madison Schank, et al.. (2021). SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Virus Research. 304. 198508–198508. 26 indexed citations
3.
4.
Wang, Ling, Juan Zhao, Lam Nhat Nguyen, et al.. (2021). Blockade of SARS-CoV-2 spike protein-mediated cell–cell fusion using COVID-19 convalescent plasma. Scientific Reports. 11(1). 5558–5558. 17 indexed citations
5.
Wang, Feng, Jianyong Yin, Yingying Lin, et al.. (2020). IL-17C has a pathogenic role in kidney ischemia/reperfusion injury. Kidney International. 97(6). 1219–1229. 29 indexed citations
6.
Kong, Yiwei, Zeyuan Lu, Pengyuan Liu, et al.. (2019). Long Noncoding RNA: Genomics and Relevance to Physiology. Comprehensive physiology. 9(3). 933–946. 24 indexed citations
7.
Kong, Yiwei, Zeyuan Lu, Pengyuan Liu, et al.. (2019). Long Noncoding RNA: Genomics and Relevance to Physiology. Comprehensive physiology. 9(3). 933–946. 1 indexed citations
8.
Wu, Rui, Yiwei Kong, Jianyong Yin, et al.. (2018). Antithrombin Ⅲ is a Novel Predictor for Contrast Induced Nephropathy After Coronary Angiography. Kidney & Blood Pressure Research. 43(1). 170–180. 12 indexed citations
9.
Lu, Zeyuan, Dongsheng Cheng, Jianyong Yin, et al.. (2017). Antithrombin III Protects Against Contrast-Induced Nephropathy. EBioMedicine. 17. 101–107. 45 indexed citations
10.
Liu, Lan, et al.. (2017). Recent findings on fulminant type 1 diabetes. Diabetes/Metabolism Research and Reviews. 34(1). 14 indexed citations
11.
Lu, Zeyuan, Jianyong Yin, Hongda Bao, et al.. (2016). Coexistence of Acute Crescent Glomerulonephritis and IgG4-Related Kidney Disease. Case Reports in Nephrology and Dialysis. 6(2). 89–95. 4 indexed citations
12.
Zhao, Qing, Jianyong Yin, Zeyuan Lu, et al.. (2016). Sulodexide Protects Contrast-Induced Nephropathy in Sprague-Dawley Rats. Cellular Physiology and Biochemistry. 40(3-4). 621–632. 19 indexed citations
13.
Lu, Zeyuan, Guangyuan Zhang, Yuting Xie, et al.. (2016). Serum levels of RBP4 might not be determined by diabetes mellitus but by kidney function and renal replacement therapy. Journal of Shanghai Jiaotong University (Science). 21(6). 757–762. 1 indexed citations
14.
Wang, Feng, Guangyuan Zhang, Zeyuan Lu, et al.. (2015). Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury. Kidney International. 88(4). 796–803. 65 indexed citations
15.
Liu, Lan, et al.. (2013). Clinical analysis of fulminant type 1 diabetes in China and comparison with a nationwide survey in Japan. Annales d Endocrinologie. 74(1). 36–39. 7 indexed citations
16.
Liu, Lan, et al.. (2012). Clinical analysis of fulminant type 1 diabetes in China and comparison with a nationwide survey in Japan. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 6(4). 203–206. 3 indexed citations
17.
Liu, Lan, et al.. (2011). Clinical characteristics of fulminant type 1 diabetes associated with pregnancy in China. Endocrine. 40(3). 408–412. 11 indexed citations
18.
Cai, Liangliang, et al.. (2011). The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. Journal of Clinical Pharmacy and Therapeutics. 37(4). 386–398. 43 indexed citations
19.
Lu, Zeyuan, et al.. (2010). Clinical analysis of five cases of fulminant type 1 diabetes mellitus. Zhonghua neifenmi daixie zazhi. 26(3). 192–194. 4 indexed citations
20.
Lu, Zeyuan, et al.. (2010). Screening and diagnosis of gestational diabetes mellitus. 30(3). 180–182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hequn Zou Breakdown of academic impact, for papers by Katherine Fredrich Breakdown of academic impact, for papers by Tomokazu Okado Breakdown of academic impact, for papers by Ryohei Kaseda Breakdown of academic impact, for papers by Stephen Zewinger Breakdown of academic impact, for papers by Kerstin Ebefors Breakdown of academic impact, for papers by Jung Sik Park Breakdown of academic impact, for papers by Pierre Galichon Breakdown of academic impact, for papers by E.S.G. Stroes
Rankless by CCL
2026